Worth reading
38Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
114065
unitsWording
Conditional
How definitive the wording is.Details of issuance or disposal
Issuance without consideration of stock acquisition rights as stock options
Intended allottee
Category The Company's directors / Number of Employees 15 / Number of Shares Not disclosed, Category Executive officers of the Company / Number of Employees 5 / Number of Shares Not disclosed, Category Directors of subsidiaries of the Company / Number of Employees 28 / Number of Shares Not disclosed, Category Audit & Supervisory Board members of the Company’s subsidiaries / Number of Employees 5 / Number of Shares Not disclosed, Category Executive officers of the Company's subsidiaries / Number of Employees 26 / Number of Shares Not disclosed, Category Employees of the Company / Number of Employees 1,519 / Number of Shares Not disclosed, Category Employees of the Company’s subsidiaries / Number of Employees 3,282 / Number of Shares Not disclosed
Terms of the stock acquisition rights
Exercise price
To be determined on 4 August 2026 based on the closing price on the allocation date. Adjustment provisions apply in connection with stock splits or consolidations, the issuance of new shares or disposal of treasury shares at a price below market value, corporate reorganizations and other events. The floor price is Not disclosed.
Exercise period
22 July 2029 to 21 July 2031
Number of Stock Acquisition Rights
Total to be issued: 114,065 stock acquisition rights (17,280 for directors and other officers and 96,785 for employees). The number of outstanding unexercised rights is Not disclosed.
Reason for acquisition without consideration
If a proposal for a merger, share exchange or share transfer is approved at a shareholders' meeting, if the conditions for exercising the rights are no longer satisfied, or if the rights are waived. Stock acquisition rights acquired and held by the Company may be cancelled free of charge at any time.
Categories and Number of Persons Covered
Category The Company's directors / Number of Employees 15 / Number of allocated shares Not disclosed, Category Executive officers of the Company / Number of Employees 5 / Number of allocated shares Not disclosed, Category Directors of subsidiaries of the Company / Number of Employees 28 / Number of allocated shares Not disclosed, Category Audit & Supervisory Board members of the Company’s subsidiaries / Number of Employees 5 / Number of allocated shares Not disclosed, Category Executive officers of the Company's subsidiaries / Number of Employees 26 / Number of allocated shares Not disclosed, Category Employees of the Company / Number of Employees 1,519 / Number of allocated shares Not disclosed, Category Employees of the Company’s subsidiaries / Number of Employees 3,282 / Number of allocated shares Not disclosed
Payment date
4 August 2026 (date of issue of the stock acquisition rights)
Basis for determining the amount to be paid
The exercise price will be the closing price of the Company's common stock in regular trading on the Tokyo Stock Exchange on the allocation date, or, if no trading takes place, the closing price on the most recent preceding trading day. The discount or premium rate is Not disclosed. The stock acquisition rights themselves will be issued free of charge.
Procedures under the Corporate Code of Conduct
At the annual shareholders' meeting held on 19 June 2026, a special resolution was approved authorizing the Board of Directors to determine the offering terms for grants to the Company's directors, executive officers and others. Grants to directors and executive officers will be made based on a decision by the Compensation Committee.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance without consideration of stock acquisition rights as stock options |
| Issue price and disposal price | No payment is required in exchange for the stock acquisition rights. |
| Payment date | 4 August 2026 (date of issue of the stock acquisition rights) |
| Intended allottee | Category The Company's directors / Number of Employees 15 / Number of Shares Not disclosed, Category Executive officers of the Company / Number of Employees 5 / Number of Shares Not disclosed, Category Directors of subsidiaries of the Company / Number of Employees 28 / Number of Shares Not disclosed, Category Audit & Supervisory Board members of the Company’s subsidiaries / Number of Employees 5 / Number of Shares Not disclosed, Category Executive officers of the Company's subsidiaries / Number of Employees 26 / Number of Shares Not disclosed, Category Employees of the Company / Number of Employees 1,519 / Number of Shares Not disclosed, Category Employees of the Company’s subsidiaries / Number of Employees 3,282 / Number of Shares Not disclosed |
| Basis for determining the amount to be paid | The exercise price will be the closing price of the Company's common stock in regular trading on the Tokyo Stock Exchange on the allocation date, or, if no trading takes place, the closing price on the most recent preceding trading day. The discount or premium rate is Not disclosed. The stock acquisition rights themselves will be issued free of charge. |
| Exercise price | To be determined on 4 August 2026 based on the closing price on the allocation date. Adjustment provisions apply in connection with stock splits or consolidations, the issuance of new shares or disposal of treasury shares at a price below market value, corporate reorganizations and other events. The floor price is Not disclosed. |
| Exercise period | 22 July 2029 to 21 July 2031 |
| Number of Stock Acquisition Rights | Total to be issued: 114,065 stock acquisition rights (17,280 for directors and other officers and 96,785 for employees). The number of outstanding unexercised rights is Not disclosed. |
| Reason for acquisition without consideration | If a proposal for a merger, share exchange or share transfer is approved at a shareholders' meeting, if the conditions for exercising the rights are no longer satisfied, or if the rights are waived. Stock acquisition rights acquired and held by the Company may be cancelled free of charge at any time. |
| Categories and Number of Persons Covered | Category The Company's directors / Number of Employees 15 / Number of allocated shares Not disclosed, Category Executive officers of the Company / Number of Employees 5 / Number of allocated shares Not disclosed, Category Directors of subsidiaries of the Company / Number of Employees 28 / Number of allocated shares Not disclosed, Category Audit & Supervisory Board members of the Company’s subsidiaries / Number of Employees 5 / Number of allocated shares Not disclosed, Category Executive officers of the Company's subsidiaries / Number of Employees 26 / Number of allocated shares Not disclosed, Category Employees of the Company / Number of Employees 1,519 / Number of allocated shares Not disclosed, Category Employees of the Company’s subsidiaries / Number of Employees 3,282 / Number of allocated shares Not disclosed |
| Procedures under the Corporate Code of Conduct | At the annual shareholders' meeting held on 19 June 2026, a special resolution was approved authorizing the Board of Directors to determine the offering terms for grants to the Company's directors, executive officers and others. Grants to directors and executive officers will be made based on a decision by the Compensation Committee. |
Items this document does not state (17)
Number of shares to be issued or disposed ofTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To increase the motivation and morale of the Nojima team to contribute to improved performance and thereby enhance corporate value.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.